← Back to home

PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL)

Clinical trials for PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL) explained in plain language.

Never miss a new study

Get alerted when new PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL) trials appear

Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope to stop deadly leukemia relapse after transplant

Disease control Not yet recruiting

This study tests whether adding a new drug called asciminib to standard maintenance therapy can better prevent leukemia from returning after a stem cell transplant. Researchers will compare two groups: one receiving the standard drug alone and another receiving the standard drug …

Matched conditions: PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL)

Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL)

Get alerted when new PHILADELPHIA CHROMOSOME-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ B-ALL) trials appear

New hope to stop deadly leukemia relapse after transplant